| CAS: | 59831-65-1 | |
| 分子式: | C21H22ClFN4O2 | |
| 分子量: | 416.88 | |
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||||||||||||
| H920748 | MACKLIN | 卤培米特 | ≥98%(HPLC) | 1360元/5mg; 2077元/10mg; 3727元/25mg; 11866元/100mg; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||
储存:2-8°C | |||||||||||||||||||||||||||||||||||||||||||||||||||
| H3041 | Sigma-Aldrich | Halopemide | ≥98% (HPLC) | 2183.98元/5 MG; 7020.25元/25 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||
产品说明 应用 Halopemide, a non-specific phospholipase D (PLD) antagonist, may be used with selective PLD antagonists (CAY10593, a PLD1 antagonist; CAY10594 or ML298, selective PLD2 antagonist) to help define the role and physiological effects regulated by phospholipase D enzymes. Halopemide may be used as the basis of the design and development of more selective PLD antagonists. 包装 5, 25 mg in glass bottle 生化/生理作用 Halopemide is a dopamine receptor antagonist and a phospholipase D2 inhibitor. Halopemide may be used as a screen to identify inhibitors of human PLD2 using an in vitro biochemical assay. It is also inhibitory at benzodiazepine binding sites. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||